NK1 RECEPTOR ANTAGONIST COMPOSITION

PROBLEM TO BE SOLVED: To provide an NK1 receptor antagonist composition which has high safety permitting to use for medicines and has a sufficient therapeutic effect. SOLUTION: The NK1 receptor antagonist composition uses arabitol as an active ingredient. The preferable content of the arabitol in th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OBAYASHI HIROKO, KIMURA MITSUO, TANAKA YOSHIMASA, MORISHITA SATOSHI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide an NK1 receptor antagonist composition which has high safety permitting to use for medicines and has a sufficient therapeutic effect. SOLUTION: The NK1 receptor antagonist composition uses arabitol as an active ingredient. The preferable content of the arabitol in the NK1 receptor antagonist composition is 0.01 to 30 mass%. The NK1 receptor antagonist composition may further be compounded with other materials as other components except the active ingredient, and used in various forms such as external preparations, internal preparations, foods, or drinks. COPYRIGHT: (C)2010,JPO&INPIT